Filipek A, Wojda U. P30, a novel protein target of mouse calcyclin(S100A6)[J]. Biochem J,1996, 320(2): 585-587.
[2]
Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses[J]. Mol Cell, 2001, 7(5): 915-926.
[3]
Jastrzebska B, Filipek A, Nowicka D, et al. Calcyclin(S100A6)binding protein(CacyBP/SIP)is highly expressed in brain neurons[J]. J Histochem Cytochem, 2000, 48(9):1195-1202.
[4]
Schneider G, Filipek A. S100A6 binding protein and Siah-1 interacting protein(CacyBP/SIP): spotlight on properties and cellular function[J]. Amino Acids,2010,(12):375.
[5]
Ning X, Sun S, Hong L, et al. Calcyclin-binding protein inhibits proliferation,tumorigenicity, and invasion of gastric cancer[J]. Mol Cancer Res, 2007, 5(12):1254-1262.
[6]
Sun S, Ning X, Liu J, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma[J]. Biochem Biophys Res Commun, 2007, 356:864-871.
[7]
ZHai H,Shi Y,Jin H,et al. Expression of calcyclin-bindingprotein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey[J]. J Histochem Cytochem,2008,56(8):765-772.
Wang N,Ma Q,Wang Y,et al.CacyBP/SIP expression is involved in the clinical progression of breast cancer[J].World J Surg,2010,34(11): 2545-2552.
[10]
Kila？czyk E, Gwodzi？ski K, Wilczek E, et al. Up-regulation of CacyBP/SIP during rat breast cancer development[J]. Breast Cancer,2012,28.
[11]
Nie F, Yu XL, Wang XG, et al. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer[J]. Int J Oncol,2010, 37(5):1261-1269.
